Facebook Rare Kidney Disease Precision Medicine: C3 Glomerulopathy Treatment Demand Forecast 2026-2032 – Role in Complement Alternative Pathway Dysregulation, End-Stage Renal Disease (ESRD) Prevention, and Eculizumab/Iptacopan Adoption
Logo

Rare Kidney Disease Precision Medicine: C3 Glomerulopathy Treatment Demand Forecast 2026-2032 – Role in Complement Alternative Pathway Dysregulation, End-Stage Renal Disease (ESRD) Prevention, and Ecu...

クレジット
Avatar
イラストレーター
Rare Kidney Disease Precision Medicine: C3 Glomerulopathy Treatment Demand Forecast 2026-2032 – Role in Complement Alternative Pathway Dysregulation, End-Stage Renal Disease (ESRD) Prevention, and Eculizumab/Iptacopan Adoption-1
シェア
Ciciの他の作品